Raymond James Financial Services Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.41M | Buy |
|
|||||
|
2024
Q2 | $1.28M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Buy |
|
|||||
|
2023
Q4 | $1.11M | Sell |
|
|||||
|
2023
Q3 | $984K | Sell |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $1.03M | Buy |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $854K | Buy |
|
|||||
|
2022
Q2 | $257K | Sell |
|
|||||
|
2022
Q1 | $359K | Sell |
|
|||||
|
2021
Q4 | $485K | Sell |
|
|||||
|
2021
Q3 | $551K | Buy |
|
|||||
|
2021
Q2 | $519K | Buy |
|
|||||
|
2021
Q1 | $467K | Sell |
|
|||||
|
2020
Q4 | $450K | Sell |
|
|||||
|
2020
Q3 | $414K | Sell |
|
|||||
|
2020
Q2 | $573K | Sell |
|
|||||
|
2020
Q1 | $530K | Buy |
|
|||||
|
2019
Q4 | $450K | Sell |
|
|||||
|
2019
Q3 | $467K | Sell |
|
|||||
|
2019
Q2 | $540K | Sell |
|
|||||
|
2019
Q1 | $617K | Sell |
|
|||||
|
2018
Q4 | $559K | Buy |
|
|||||
|
2018
Q3 | $660K | Buy |
|
|||||
|
2018
Q2 | $596K | Sell |
|
|||||
|
2018
Q1 | $628K | Sell |
|
|||||
|
2017
Q4 | $767K | Sell |
|
|||||
|
2017
Q3 | $1.39M | Buy |
|
|||||
|
2017
Q2 | $974K | Buy |
|
|||||
|
2017
Q1 | $278K | Sell |
|
|||||
|
2016
Q4 | $265K | Buy |
|
|||||
|
2016
Q3 | $280K | Buy |
|
|||||
|
2016
Q2 | $246K | Buy |
|
|||||
|
2016
Q1 | $236K | Sell |
|
|||||
|
2015
Q4 | $522K | Sell |
|
|||||
|
2015
Q3 | $511K | Buy |
|